3 Top Biotech Stocks for Spring 2021
What do playing right field in baseball, deep-sea fishing, and investing in small biotech stocks have in common? For shareholders of bluebird bio (NASDAQ: BLUE), Sage Therapeutics (NASDAQ: SAGE), and Trillium Therapeutics (NASDAQ: TRIL), spring announcements may pierce the monotony with updates on key drug development programs. After those stocks' recent struggles, management teams and shareholders are hoping the news will get their share prices moving back toward previous highs.